Evidence suggests that oxidative stress and mitochondrial dysfunction may be involved in neurodegeneration associated with Huntington's disease (HD). However, it is not clear whether oxidative damage to the mitochondrial DNA (mtDNA) and the repair of this damage are primary events in the neuropathogenesis of HD. Mitochondrial dysfunction and increased production of mitochondrial-generated reactive oxygen species (ROS) may contribute to neurodegeneration associated with HD. We hypothesize that mitochondrial dysfunction may occur as a consequence of increased levels of mtDNA damage and deficient repair. In this research proposal we will determine the relationship between mtDNA damage and repair and the neurodegeneration observed in HD. For this purpose we will use a transgenic mouse model of HD and a chemically-induced HD model using the mitochondrial toxin 3-nitropropionic acid (3-NPA).
The specific aims of this study are: 1) to determine brain regional differences in the levels of mitochondrial DNA damage and protein expression in a transgenic animal model of HD and if administration of superoxide dismutase (SOD) mimetics to the HD transgenic animals can attenuate oxidative stress and onset of the disease; 2) to develop a mouse neuronal cell model to study the relationship between mitochondrial DNA damage, loss of mitochondrial function, and cell death after exposure to 3-NPA and the effects resulting from administration of SOD mimetics; and 3) to determine the role of base excision repair genes in the repair of 3-NPA-induced mitochondrial DNA damage in mouse primary neuronal cell cultures. This study will lead to a better understanding of mitochondrial-linked neurodegeneration associated with liD, with particular emphasis in the role of mtDNA damage, repair of mtDNA damage, and mitochondrial dysfunction.
Showing the most recent 10 out of 54 publications
